ThyroNet-X4 genesis: an advanced deep learning model for auxiliary diagnosis of thyroid nodules' malignancy.

Journal: Scientific reports
PMID:

Abstract

Thyroid nodules are a common endocrine condition, and accurate differentiation between benign and malignant nodules is essential for making appropriate treatment decisions. Traditional ultrasound-based diagnoses often depend on the expertise of physicians, which introduces a risk of misdiagnosis. To address this challenge, this study proposes a novel deep learning model, ThyroNet-X4 Genesis, designed to automatically classify thyroid nodules as benign or malignant. Built on the ResNet architecture, the model enhances feature extraction by incorporating grouped convolutions and using larger convolution kernels, improving its ability to analyze thyroid ultrasound images. The model was trained and validated using publicly available thyroid ultrasound imaging datasets, and its generalization was further tested using an external validation dataset from HanZhong Central Hospital. The ThyroNet-X4 Genesis model achieved 85.55% and 71.70% accuracy on the internal training and validation sets, respectively, and 67.02% accuracy on the external validation set. These results surpass those of other mainstream models, highlighting its potential for clinical use in thyroid nodule classification. This work underscores the growing role of deep learning in thyroid nodule diagnosis and provides a foundation for future research in high-performance medical diagnostic models.

Authors

  • Xiaoxue Wang
    HanZhong Central Hospital, HanZhong, 723000, China.
  • Yupeng Niu
    College of Information Engineering, Sichuan Agricultural University, Ya'an, 625000, China.
  • Hongli Liu
    Key Laboratory for Control Theory & Applications in Complicated Systems, Tianjin University of Technology, Tianjin 300384, China.
  • Fa Tian
    College of Information Engineering, Sichuan Agricultural University, Ya'an, 625000, China.
  • Qiang Zhang
    Yunan Provincial Center for Disease Control and Prevention, Kunming 650022, China.
  • Yimeng Wang
    Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China.
  • Yeju Wang
    HanZhong Central Hospital, HanZhong, 723000, China.
  • Yijia Li
    HanZhong Central Hospital, HanZhong, 723000, China. OLALA110437@163.com.